A detailed history of Vanguard Group Inc transactions in Psychemedics Corp stock. As of the latest transaction made, Vanguard Group Inc holds 251,283 shares of PMD stock, worth $472,412. This represents 0.0% of its overall portfolio holdings.

Number of Shares
251,283
Previous 251,283 -0.0%
Holding current value
$472,412
Previous $608,000 4.61%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$2.06 - $3.69 $271 - $487
132 Added 0.05%
251,283 $743,000
Q3 2023

Nov 14, 2023

BUY
$3.66 - $5.05 $13,589 - $18,750
3,713 Added 1.5%
251,151 $997,000
Q4 2022

Feb 10, 2023

BUY
$4.9 - $6.7 $480 - $656
98 Added 0.04%
247,438 $1.21 Million
Q4 2021

Feb 14, 2022

SELL
$6.86 - $8.79 $1,934 - $2,478
-282 Reduced 0.11%
247,340 $1.74 Million
Q3 2021

Nov 12, 2021

SELL
$6.31 - $8.4 $6,802 - $9,055
-1,078 Reduced 0.43%
247,622 $2.08 Million
Q2 2021

Aug 13, 2021

BUY
$6.25 - $8.25 $1.55 Million - $2.05 Million
248,700 New
248,700 $1.73 Million

Others Institutions Holding PMD

About PSYCHEMEDICS CORP


  • Ticker PMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 5,626,200
  • Market Cap $10.6M
  • Description
  • Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...
More about PMD
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.